Evidence map›Paper›PMID 34950780›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.

Zhanwei Wang, Anuradha S Budhu, Yi Shen, Linda Lou Wong, Brenda Y Hernandez, Maarit Tiirikainen, Xiaomei Ma, Melinda L Irwin, Lingeng Lu, Hongyu Zhao and 29 more

Open access · goldAbstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Genetic Variants ofJournal of hepatocellular carcinoma · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Genetic Variation ofInternational journal of molecular sciences · 2022
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 16 institutions in 4 countries.

Zhanwei WangUniversity of Hawaii Cancer Center Honolulu Hawaii USA.
Anuradha S BudhuLaboratory of Human Carcinogenesis, Liver Cancer Program, Center for Cancer Research National Cancer Institute Bethesda Maryland USA.
Yi ShenUniversity of Hawaii Cancer Center Honolulu Hawaii USA.
Linda Lou WongUniversity of Hawaii Cancer Center Honolulu Hawaii USA.ORCID https://orcid.org/0000-0003-3143-5384
Brenda Y HernandezUniversity of Hawaii Cancer Center Honolulu Hawaii USA.
Maarit TiirikainenUniversity of Hawaii Cancer Center Honolulu Hawaii USA.
Xiaomei MaYale School of Public Health New Haven Connecticut USA.
Melinda L IrwinYale School of Public Health New Haven Connecticut USA.
Lingeng LuYale School of Public Health New Haven Connecticut USA.
Hongyu ZhaoYale School of Public Health New Haven Connecticut USA.
Joseph K LimYale School of Medicine New Haven Connecticut USA.
Tamar TaddeiYale School of Medicine New Haven Connecticut USA.
Lopa MishraCenter for Translational Medicine, Department of Surgery The George Washington University Washington District of Columbia USA.
Karen PawlishNew Jersey State Cancer Registry, New Jersey Department of Health Trenton New Jersey USA.
Antoinette StroupRutgers Cancer Institute, and Rutgers School of Public Health New Brunswick New Jersey USA.
Robert BrownWeill Cornell Medical College, and College of Physicians and Surgeons, Columbia University New York New York USA.
Mindie H NguyenDivision of Gastroenterology and Hepatology Stanford University Medical Center Palo Alto California USA.
Jill KoshiolDivision of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland USA.
Maria O HernandezLaboratory of Human Carcinogenesis Center for Cancer Research, National Cancer Institute Bethesda Maryland USA.
Marshonna ForguesLaboratory of Human Carcinogenesis Center for Cancer Research, National Cancer Institute Bethesda Maryland USA.
Hwai-I YangGenomics Research Center, Academia Sinica Taipei Taiwan.
Mei-Hsuan LeeInstitute of Clinical Medicine, National Yang Ming University Taipei Taiwan.
Yu-Han HuangInstitute of Clinical Medicine, National Yang Ming University Taipei Taiwan.
Motoki IwasakiDivision of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan.
Atsushi GotoDivision of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan.
Shiori SuzukiDivision of Epidemiology Center for Public Health Sciences, National Cancer Center Tokyo Japan.
Koichi MatsudaGraduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan.
Chizu TanikawaGraduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan.
Yoichiro KamataniGraduate School of Frontier Sciences, and Institute of Medical Science, University of Tokyo Tokyo Japan.
Dean MannDepartment of Pathology University of Maryland School of Medicine Baltimore Maryland USA.
Maria GuarneraDepartment of Pathology University of Maryland School of Medicine Baltimore Maryland USA.
Kirti ShettyDepartment of Gastroenterology and Hepatology University of Maryland School of Medicine Baltimore Maryland USA.
Claire E ThomasDivision of Cancer Control and Population Sciences University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania USA.
Jian-Min YuanDivision of Cancer Control and Population Sciences University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center Pittsburgh Pennsylvania USA.
Chiea Chuen KhorGenome Institute of Singapore, Agency for Science, Technology and Research Singapore Singapore.
Woon-Puay KohHealth Systems and Services Research, Duke-NUS Medical School Singapore Singapore Singapore.
Harvey RischYale School of Public Health New Haven Connecticut USA.
Xin Wei WangLaboratory of Human Carcinogenesis, Liver Cancer Program, Center for Cancer Research National Cancer Institute Bethesda Maryland USA.
Herbert YuUniversity of Hawaii Cancer Center Honolulu Hawaii USA.ORCID https://orcid.org/0000-0003-3950-4815
University of Hawaiʻi at Mānoa · USNational Cancer Institute · USYale New Haven Health System · USNational Center for Global Health and Medicine · JPNational Yang Ming Chiao Tung University · TWTokyo University of Science · JPUniversity of Maryland, Baltimore · USUniversity of Pittsburgh · USYale University · USAgency for Science, Technology and Research · SGCornell University · USGeorge Washington University · USNational University of Singapore · SGNew Jersey Department of Health · USRutgers, The State University of New Jersey · USStanford Medicine · US

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2M
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
Epidemiologic Study of Hepatocellular Carcinoma in the USR01CA138698 · NCI · YALE UNIVERSITY · PI YU, HERBERT · 2010 to 2015
$5.7M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
Pathway Specific Functional Biomarkers for the Early Detection of Liver CancerU01CA230690 · NCI · GEORGE WASHINGTON UNIVERSITY · PI MISHRA, LOPA, SHETTY, KIRTI · 2018 to 2022
$3.4M
Translational Research Training in Cancer Prevention and ControlT32CA186873 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Kathryn H. Schmitz, Jian-Min Yuan · 2014 to 2026
$2.7M
NCI NIH HHS P30 CA071789NCI NIH HHS R01 CA138698NCI NIH HHS R01 CA144034NCI NIH HHS T32 CA186873NCI NIH HHS U01 CA230690NCI NIH HHS UM1 CA182876
6 · The paper itself

Abstract

BACKGROUND AND

aimChronic hepatitis C virus (HCV) infection, long-term alcohol use, cigarette smoking, and obesity are the major risk factors for hepatocellular carcinoma (HCC) in the United States, but the disease risk varies substantially among individuals with these factors, suggesting host susceptibility to and gene-environment interactions in HCC. To address genetic susceptibility to HCC, we conducted a genome-wide association study (GWAS).

methodsTwo case-control studies on HCC were conducted in the United States. DNA samples were genotyped using the Illumian microarray chip with over 710 000 single nucleotide polymorphisms (SNPs). We compared these SNPs between 705 HCC cases and 1455 population controls for their associations with HCC and verified our findings in additional studies.

resultsIn this GWAS, we found that two SNPs were associated with HCC at

conclusionsSNPs in

Indexed as

genome‐wide association studyliver cancernonalcoholic fatty liver diseasePNPLA3SAMM50

Identifiers

PMID34950780
PMCPMC8674550
OpenAlexW3215130763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.